EXHIBIT 10.79
[CONFIDENTIAL TREATMENT REQUESTED]
[Certain information has been omitted herein pursuant to a request for
confidential treatment pursuant to Rule 24b-2.]
[letterhead]
September 29, 1995
Xx. Xxxx Xxxxxxxxx
Xxxx-Geigy Limited
CH-4002 Basel
Re: Investment, Research Support and Marketing Agreement
Dear Xxxx:
This letter relates to the Investment, Research Support and Marketing
Agreement dated as of September 29, 1995 (the "Research Support Agreement").
Chiron Corporation ("Chiron") and Ciba-Geigy Limited ("Ciba") hereby confirm
that the obligation of Ciba to purchase Newco Stock under Article 2 of the
Research Support Agreement shall be limited to the initial purchase on
September 29, 1995, of 12,000 shares, at a purchase price of U.S.
$12,000,000, until such time as
(i) product rights to [CONFIDENTIAL TREATMENT REQUESTED] (or other
products), all as acceptable to Ciba, are added to Newco pursuant to
Section 1.04 of the Research Support Agreement, on terms which are mutually
approved by Xxxxxx and Ciba; and
(ii) Ciba has completed its internal review and approval of the Research
Support Agreement, and the parties have made such adjustments to the
Research Support Agreement as are required as a result of such internal
review, on terms which are mutually agreed upon.
Chiron and Xxxx expect to complete these steps within the next thirty (30) days.
Sincerely,
Chiron Corporation
By /s/ Xxxxxx Xxxxxx
---------------------
Title President
-----------------
Agreed: Ciba-Geigy Limited
By /s/ X.X. Xxxxx /s/ Xxxxxxx Xxx
---------------------- -------------------
Title Member of the Executive Committee/CFO Senior Division Counsel
------------------------------------- -----------------------
